Details for New Drug Application (NDA): 090474
✉ Email this page to a colleague
NDA 090474 describes CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF, which is a drug marketed by Amneal Pharms, Apozeal Pharms, Aurobindo Pharma, Bajaj, Chartwell Molecular, Chartwell Rx, Cypress Pharm, Perrigo R And D, Pharm Assoc, Ranbaxy Labs Ltd, Taro, Tris Pharma Inc, Jubilant Generics, and Sun Pharm, and is included in fifteen NDAs. It is available from twenty-six suppliers. Additional details are available on the CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF profile page.
The generic ingredient in CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF is cetirizine hydrochloride. There are thirty-nine drug master file entries for this compound. One hundred and fifty-eight suppliers are listed for this compound. Additional details are available on the cetirizine hydrochloride profile page.
The generic ingredient in CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF is cetirizine hydrochloride. There are thirty-nine drug master file entries for this compound. One hundred and fifty-eight suppliers are listed for this compound. Additional details are available on the cetirizine hydrochloride profile page.
Summary for 090474
| Tradename: | CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF |
| Applicant: | Apozeal Pharms |
| Ingredient: | cetirizine hydrochloride |
| Patents: | 0 |
Pharmacology for NDA: 090474
| Mechanism of Action | Histamine H1 Receptor Antagonists |
Medical Subject Heading (MeSH) Categories for 090474
Suppliers and Packaging for NDA: 090474
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY | cetirizine hydrochloride | SOLUTION;ORAL | 090474 | ANDA | Dolgencorp, Inc. (DOLLAR GENERAL & REXALL) | 55910-878 | 55910-878-04 | 118 mL in 1 BOTTLE, PLASTIC (55910-878-04) |
| CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF | cetirizine hydrochloride | SOLUTION;ORAL | 090474 | ANDA | Dolgencorp, Inc. (DOLLAR GENERAL & REXALL) | 55910-878 | 55910-878-04 | 118 mL in 1 BOTTLE, PLASTIC (55910-878-04) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION;ORAL | Strength | 5MG/5ML | ||||
| Approval Date: | Mar 30, 2009 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION;ORAL | Strength | 5MG/5ML | ||||
| Approval Date: | Mar 30, 2009 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
